Effects of Lifestyle Modification on Intrapancreatic Fat Deposition: A Systematic Review and Meta-Analysis
Open Access
- 20 July 2026
- journal article
- review article
- Published by Springer Nature in Current Obesity Reports
- Vol. 15 (1) , 60
Abstract
Background & Aims: Lifestyle modification is a well-established approach for improving metabolic health and reducing ectopic fat accumulation in the liver. The Melbourne Consensus has recently highlighted intrapancreatic fat deposition (IPFD) as an important fat depot, playing a key role in the development of both endocrine and exocrine pancreatic diseases. Nevertheless, the existing literature on the impact of lifestyle modification on IPFD has not been systematically synthesized. We conducted a comprehensive systematic review and meta-analysis to assess the effects of lifestyle modification on IPFD. Methods: A systematic literature search was conducted in PubMed and Embase databases to identify interventional studies evaluating the effects of lifestyle modification on IPFD measured by magnetic resonance-based techniques. Data were meta-analyzed using a random-effects model. Statistical heterogeneity was assessed using the I² statistic, and publication bias was evaluated with Egger’s test. Results: A total of 23 studies were included. Lifestyle modification resulted in a significant reduction in IPFD (standardized mean difference [SMD] -0.26, 95% CI -0.36 to -0.16; p2 =12.9%). The pooled absolute reduction in MRI-measured IPFD was −1.02 % (95% CI −1.30 to −0.73; p2 =0%). Subgroup analyses showed the largest numerical reduction in IPFD with combined diet-and-exercise interventions (SMD -0.41, 95% CI -0.81 to -0.02, I 2 =29.4%), followed by exercise alone (SMD -0.26, 95% CI -0.36 to -0.15, I 2 =0%) and diet alone (SMD -0.22, 95% CI -0.37 to -0.08, I 2 =27.9%). However, differences between intervention types were not statistically significant (p=0.40). There was no evidence of publication bias (p = 0.78). Conclusion: Lifestyle modification is an effective non-pharmacological approach for reducing IPFD, with combined diet-and-exercise interventions showing the largest numerical effect. These findings support the potential of structured lifestyle modification programs to reduce IPFD and may have implications for the prevention and management of pancreatic diseases.Keywords
Funding Information
- University of Auckland
This publication has 67 references indexed in Scilit:
- Effect of Calorie Restricted Diet Versus Liraglutide on Intrapancreatic Fat Deposition in People With Obesity: A Pilot StudyObesity, 2026
- Artificial intelligence-based models for quantification of intra-pancreatic fat deposition and their clinical relevance: a systematic review of imaging studiesEuropean Radiology, 2025
- Quantification of ectopic fat storage in the liver and pancreas using six-point Dixon MRI and its association with insulin sensitivity and β-cell function in patients with central obesityEuropean Radiology, 2023
- Effects of a Family-Based Lifestyle Intervention Plus Supervised Exercise Training on Abdominal Fat Depots in Children With Overweight or ObesityJAMA Network Open, 2022
- Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trialDiabetologia, 2022
- Aerobic training reduces pancreatic fat content and improves β‐cell function: A randomized controlled trial using IDEAL‐IQ magnetic resonance imagingDiabetes/Metabolism Research and Reviews, 2021
- MOOSE Reporting Guidelines for Meta-analyses of Observational StudiesJAMA Surgery, 2021
- A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trialDiabetologia, 2019
- Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trialDiabetologia, 2018
- Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerolDiabetologia, 2011